Jiayu Liu

A targeted IL-15 fusion protein with potent anti-tumor activity.

BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.

A Bispecific Antibody Based on Pertuzumab Fab Has Potent Antitumor Activity.

Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells.

A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities.

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.

A HER2 bispecific antibody can be efficiently expressed in with potent cytotoxicity.